This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: University of California. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Volodymyr Ryzhuk
Introduction
Volodymyr Ryzhuk is a notable inventor based in Sacramento, California. He has made significant contributions to the field of biomedical engineering, particularly in the area of cell delivery and inflammation prevention. His innovative work has the potential to impact therapeutic applications in both in vivo and in vitro settings.
Latest Patents
Ryzhuk holds a patent for a decellularized human amniotic membrane, which is designed for cell delivery, cell culture, and inflammation prevention. The patent details an isolated decellularized amniotic membrane (DCM) and methods for its therapeutic use. The DCM can be further processed through freezing, freeze-drying, lyophilization, or treatment with pepsin to create a hydrogel, enhancing its utility in medical applications.
Career Highlights
Volodymyr Ryzhuk is affiliated with the University of California, where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical technologies and patient outcomes through innovative solutions.
Collaborations
Ryzhuk collaborates with esteemed colleagues, including Aijun Wang and Benjamin A Keller. Their combined expertise fosters a dynamic research environment that encourages groundbreaking discoveries.
Conclusion
Volodymyr Ryzhuk's contributions to the field of biomedical engineering exemplify the spirit of innovation. His patented work on decellularized human amniotic membranes showcases the potential for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
